Teaching
Modules for 2024-25
Cancer Clinical Trials
Module code: LIFE726
Role: Teaching
Frontiers in Cancer Research and Treatment
Module code: LIFE724
Role: Teaching
INTRODUCTION TO RESEARCH
Module code: LIFE702
Role: Teaching
MOLECULAR AND MEDICAL GENETICS
Module code: LIFE208
Role: Teaching
MOLECULAR, CLINICAL AND TRANSLATIONAL CANCER
Module code: LIFE373
Role: Teaching
Supervised Theses
- BI 6727 and gemcitabine combination therapy in pancreatic cancer
- EVALUATION OF UHRF1 AND THE ANTIOXIDANT RESPONSE PATHWAY IN PANCREATIC CANCER AND THE PREDICTION OF RESPONSE TO TREATMENT
- Factors which influence penetrance in Familial Pancreatic Cancer
- Gene expression and micro RNA profiling in acute pancreatitis
- Investigating the Mechanism of Aurora B Transport by the Kinesin Motor MKlp2
- MODELLING THE INTERACTIONS BETWEEN PANCREATIC TUMOUR CELLS AND CANCER-ASSOCIATED FIBROBLASTS: ENHANCING MODELS FOR DRUG DEVELOPMENT
- Mechanisms of gemcitabine resistance in pancreatic cancer
- Molecular Analysis of Circulating Tumour Cells in Pancreatic Cancer
- THE INVESTIGATION OF AT7519 (CDK INHIBITOR) AND AT13387 (HSP90 INHIBITOR) AS NOVEL THERAPIES FOR THE TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA
- The Role of Nrf2 in Pancreatic Cancer and the Evaluation of Brusatol as a Chemotherapeutic Agent